Telavancin

Vibativ 750 mg polvo para concentrado para solucion para perfusion

750 mg polvo para concentrado para solución para perfusiónSpainWithdrawnAuthorised 22 Jul 2014

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

VibativCanada · 250 MG / VIAL · Powder For Solution · Pendopharm Division of Pharmascience INCSame brand
VibativCanada · 750 MG / VIAL · Powder For Solution · Pendopharm Division of Pharmascience INCSame brand
VibativEuropean Union · Astellas Pharma Europe B. V.Same brand
VibativEuropean Union · Theravance Biopharma Ireland UmitedSame brand
VIBATIV (10 vials)Saudi Arabia · Hospira INC. McphersonSame brand
VibativSaudi Arabia · Hospira INC. McphersonSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Telavancin

Vibativ 750 mg polvo para concentrado para solucion para perfusion

750 mg polvo para concentrado para solución para perfusiónSpainWithdrawnAuthorised 22 Jul 2014

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

VibativUnited States · 250MG, 750MG · injectable · Theravance INC

VibativUnited States · 250MG BASE/VIAL, 750MG BASE/VIAL · powder · Cumberland

Packs

Pack	Code	Status
Vibativ 750 mg polvo para concentrado para solucion para perfusion 1 vial de 50 ml	703100

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Telavancin
Strength: 750 mg
Dosage form: polvo para concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 22 Jul 2014
Registration: 111705002
Marketing authorisation holder: Theravance Biopharma Ireland Limited
Procedure: EU centralised
Supply: Uso Hospitalario